-
-
-
-
Description
- N-acylated analog of PTX005
-
-
Target Organism
-
- Gram-negative bacteria:
E. coli J96 (MIC90=0.08X10-6 M), E. coli H5 (MIC90=0.08X10-6 M), E. coli IA2 (MIC90=0.1X10-6 M), Pseudomonas aeruginosa (MIC90=0.03X10-6 M); - Gram-positive bacteria:
Staphlococcus aureus MN8 (MIC90=0.07X10-6 M), Staphlococcus aureus MNHO (MIC90=0.06X10-6 M), Staphlococcus aureus Eaton (drug-resistant strains) (MIC90=0.16X10-6 M), Staphlococcus aureus Wilson (drug-resistant strains) (MIC90=3.2X10-6 M).
-
Reference
-
- Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. (2006).
-
Medical use
- Broad-spectrum antimicrobial;Antiendotoxin
-
-
Stage of Development
- Preclinical
-
-